Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Aegerion Pharmaceuticals Limited

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Aegerion Pharmaceuticals Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 14

  1. John Mcevoy 2019-2023 Director View profile
  2. David John Glennane 2019-2023 Director View profile
  3. Benjamin Scott Harshbarger 2017-2019 Director View profile
  4. Barbara Chan 2017-2019 Director View profile
  5. David Allmond 2016-2017 Director View profile
  6. David Henrik Seeberger 2016-2017 Director View profile
  7. Julian William Trimming 2016-2017 Director View profile
  8. Janet Louise Kidd 2016-2017 Director View profile
  9. Massimo Boriero 2013-2015 Director View profile
  10. Mark Rothera 2012-2013 Director View profile
  11. Anne Marie Cook 2012-2014 Director View profile
  12. Jean-Yves Philippe Boursier 2012-2016 Director View profile
  13. Ailish Hogan 2019-2024 Secretary View profile
  14. Anne Marie Cook 2012-2014 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
21/06/2012

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Aegerion Pharmaceuticals Limited is controlled by Amryt Pharma Holdings Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2019-09-24 · source: Companies House PSC register
  2. Amryt Pharma Holdings Limited is controlled by Amryt Pharma Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2019-09-24 · source: Companies House PSC register
  3. Amryt Pharma Limited is controlled by John Mcevoy
    Evidence
    ceased 75-100% shares, 75-100% voting · notified 2019-07-17, ceased 2019-09-24 · source: Companies House PSC register

Ultimately controlled by John Mcevoy.

12 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

2.5y median 2.5y
average tenure
3.1y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (1)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 3Retail and trade 3

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
08114919
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data